Blog

Andrea Casadei Gardini: The best therapeutic sequence in HCC patients treated with first-line immunotherapy remains unanswered to this day

Andrea Casadei Gardini/X

Oct 16, 2024, 13:28

Andrea Casadei Gardini: The best therapeutic sequence in HCC patients treated with first-line immunotherapy remains unanswered to this day

Andrea Casadei Gardini, Associate Professor at Università Vita-Salute San Raffaele, shared a post on X:

“Our last paper —>The best therapeutic sequence in patients with advanced stage hepatocellular carcinoma treated with first-line immunotherapy remains unanswered to this day.

Here the work..”

Lenvatinib versus sorafenib second-line therapy in patients with hepatocellular carcinoma progressed to atezolizumab plus bevacizumab: a retrospective real-world study

Authors: Mara Persano, et al.

Andrea Casadei Gardini: The best therapeutic sequence in HCC patients treated with first-line immunotherapy remains unanswered to this day

advanced stage hepatocellular carcinoma Andrea Casadei Gardini cancer cancer awareness cancer care fight against cancer Global fight against cancer hepatocellular carcinoma Mara Persano OncoDaily Oncology

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Special Coverage